| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01561508 Details | 2012-12-24 Interventional | 2 | 0 | Butyric Acid Diabetes Mellit… | Unable to obtain IND currently - | |||
| NCT01064973 Details | 2012-12-20 Interventional | 2 | 32 | Baclofen Autism Spectrum… Autistic Disord… Child Developme… Autism Spectrum… | all active subjects were rolled into study 209AS209/NCT01706523 - | |||
| NCT01013480 Details | 2012-12-20 Interventional | 2 | 45 | Baclofen Fragile X Syndr… Syndrome | all active subjects rolled into 209FX303/NCT01013480 - | |||
| NCT00977054 Details | 2012-12-20 Interventional | 4 | 59 | Interferon alph… Interferon-alfa… Interferon-alph… Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C | Novel HCV DAA approved by FDA - | |||
| NCT01337518 Details | 2012-12-18 Interventional | 1 | - | Androgens Prostatic Neopl… Prostatic Neopl… | Reassessment of strategic direction - | |||
| NCT00879073 Details | 2012-12-18 Interventional | 1 | 12 | Bendamustine Hy… Brain Neoplasms Neoplasm Metast… Brain Metastase… | Principal Investigator is leaving Moffitt - | |||
| NCT00288444 Details | 2012-12-18 Interventional | 1 | 38 | Docetaxel Lonafarnib Colorectal Neop… Sarcoma Breast Cancer Colorectal Carc… Lung Cancer Prostate Cancer Soft Tissue Sar… | - - | |||
| NCT01528930 Details | 2012-12-17 Interventional | 2 | 0 | Amikacin Lung Diseases Pulmonary Non-t… | Although this study was approved at the Institutional Review Board, Korea Food & Drug
Administration (KFDA) did not approve this study due to safety concern. - | |||
| NCT01015664 Details | 2012-12-17 Interventional | 1/2 | 11 | Cetuximab MTOR Inhibitors Sirolimus Temsirolimus Carcinoma Carcinoma, Squa… Squamous Cell C… Squamous Cell C… | - - | |||
| NCT00194857 Details | 2012-12-17 Interventional | 4 | - | Epoetin Alfa Anemia Hepatitis Hepatitis A Hepatitis C Neutropenia HIV Infections Hepatitis C Vir… | - - | |||
| NCT01445938 2010-021398-36 Details | 2012-12-13 Interventional | 2 | 20 | Lumefantrine Malaria | Data Monitoring Committee recommendation - | |||
| NCT00850499 Details | 2012-12-12 Interventional | 2 | 12 | Bortezomib Fludarabine Rituximab Lymphoma Lymphoma, Folli… Follicular Lymp… | - Early termination leading to small numbers of subjects analyzed | |||
| NCT01746641 Details | 2012-12-11 Interventional | 4 | 69 | Propofol Remifentanil Pain | Occurrence of severe respiratory depression in the remifentanil group. - | |||
| NCT00591916 Details | 2012-12-11 Interventional | 2/3 | 0 | Hyaluronic Acid Thrombin Burn | Donor site material (scarlet red ) came back on the market, therefore new treatements for donor
sites was not needed. - | |||
| NCT01185223 Details | 2012-12-10 Interventional | 3 | - | Ganciclovir Ganciclovir tri… Valganciclovir Allogeneic Stem… | - - | |||
| NCT00711204 Details | 2012-12-10 Interventional | 4 | 0 | Donepezil Alzheimer Disea… Severe Alzheime… | No patients were enrolled in the study. - | |||
| NCT01675973 Details | 2012-12-06 Interventional | 1 | 4 | Ranolazine Renal Insuffici… Severe Renal Im… | Study met stopping criteria specified within protocol. - | |||
| NCT00760032 Details | 2012-12-05 Interventional | 4 | 0 | Ciprofloxacin Ascites Fibrosis Cirrhosis Infections | was not possible to measure LBP levels because we cannot found the kit - | |||
| NCT00579020 Details | 2012-12-05 Interventional | 2 | 144 | BB 1101 Dexamethasone Dexamethasone 2… Dexamethasone a… Moxifloxacin Norgestimate, e… Ophthalmic Solu… Pharmaceutical … Corneal Infiltr… | Management decision - | |||
| NCT00790855 Details | 2012-12-04 Interventional | 1/2 | 27 | Bendamustine Hy… Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Precursor Cell … Preleukemia Syndrome Acute Lymphobla… Acute Myeloid L… Chronic Myeloid… Myelodysplastic… | Lack of Response - |